Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Logo for

Mol. Cell. Biol. 26 (24): 9338-9351

Copyright © 2006 by the American Society for Microbiology. All rights reserved.

Suppression of Insulin Receptor Substrate 1 (IRS-1) Promotes Mammary Tumor Metastasis{triangledown}

Zhefu Ma,1 Shannon L. Gibson,1 Maura A. Byrne,1 Junran Zhang,2 Morris F. White,3, and Leslie M. Shaw1*

Department of Cancer Biology, University of Massachusetts Medical School, Worcester, Massachusetts 01605,1 Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri 63108,2 Howard Hughes Medical Institute, Children's Hospital, Division of Endocrinology, Harvard Medical School, Boston, Massachusetts 021153

Received for publication 8 June 2006. Revision received 15 August 2006. Accepted for publication 2 October 2006.

Abstract: The insulin receptor substrate (IRS) proteins are cytoplasmic adaptors that organize signaling complexes downstream of activated cell surface receptors. Here, we show that IRS-1 and IRS-2, despite significant homology, play critical yet distinct functions in breast cancer, and we identify specific signaling pathways that are influenced by IRS-1 using the polyoma virus middle-T (PyV-MT) transgenic mouse model of mammary carcinoma and Irs-1 null (Irs1–/–) mice. The absence of Irs-1 expression enhanced metastatic spread significantly without a significant effect on primary tumor growth. Orthotopic transplant studies revealed that the increased metastatic potential of Irs1-deficient tumor cells is cell autonomous. Mammary tumors that developed in PyV-MT::Irs1–/– mice exhibited elevated Irs-2 function and enhanced phosphatidylinositol 3-kinase/Akt/mTor activity, suggesting that one mechanism by which Irs-1 impedes metastasis is to suppress Irs-2-dependent signaling. In support of this mechanism, reduction of Irs-2 expression in Irs1–/– tumor cells restored mTor signaling to wild-type levels. PyV-MT::Irs1–/– tumors also exhibited a significant increase in vascular endothelial growth factor expression and microvessel density, which could facilitate their dissemination. The significance of our findings for human breast cancer is heightened by our observation that Irs-1 is inactivated in wild-type, metastatic mammary tumors by serine phosphorylation. Collectively, our findings reveal that inactivation of IRS-1 enhances breast cancer metastasis and support the novel hypothesis that IRS-1 has metastasis suppressor functions for breast cancer.


* Corresponding author. Mailing address: Department of Cancer Biology, University of Massachusetts Medical School, 364 Plantation St., LRB 409, Worcester, MA 01605. Phone: (508) 856-8675. Fax: (508) 856-1310. E-mail: leslie.shaw{at}umassmed.edu.

{triangledown} Published ahead of print on 9 October 2006.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Insulin Receptor Substrate Regulation of Phosphoinositide 3-Kinase.
H. E. Metz and A. McGarry Houghton (2011)
Clin. Cancer Res. 17, 206-211
   Abstract »    Full Text »    PDF »
From man to mouse and back again: advances in defining tumor AKTivities in vivo.
D. F. Restuccia and B. A. Hemmings (2010)
Dis. Model. Mech. 3, 705-720
   Abstract »    Full Text »    PDF »
Adaptor Proteins as Targets for Cancer Prevention.
D. Yee (2010)
Cancer Prevention Research 3, 263-265
   Abstract »    Full Text »    PDF »
IRS1 Regulation by Wnt/{beta}-Catenin Signaling and Varied Contribution of IRS1 to the Neoplastic Phenotype.
G. T. Bommer, Y. Feng, A. Iura, T. J. Giordano, R. Kuick, H. Kadikoy, D. Sikorski, R. Wu, K. R. Cho, and E. R. Fearon (2010)
J. Biol. Chem. 285, 1928-1938
   Abstract »    Full Text »    PDF »
O-Linked N-Acetylglucosamine Modification of Insulin Receptor Substrate-1 Occurs in Close Proximity to Multiple SH2 Domain Binding Motifs.
A. L. Klein, M. N. Berkaw, M. G. Buse, and L. E. Ball (2009)
Mol. Cell. Proteomics 8, 2733-2745
   Abstract »    Full Text »    PDF »
Hypoxia Regulates Insulin Receptor Substrate-2 Expression to Promote Breast Carcinoma Cell Survival and Invasion.
K. Mardilovich and L. M. Shaw (2009)
Cancer Res. 69, 8894-8901
   Abstract »    Full Text »    PDF »
Insulin Receptor Substrate-1 Suppresses Transforming Growth Factor-{beta}1-Mediated Epithelial-Mesenchymal Transition.
J. Shi, D.-M. Wang, C.-M. Wang, Y. Hu, A.-H. Liu, Y.-L. Zhang, B. Sun, and J.-G. Song (2009)
Cancer Res. 69, 7180-7187
   Abstract »    Full Text »    PDF »
Insulin Receptor Substrate-2 Regulates Aerobic Glycolysis in Mouse Mammary Tumor Cells via Glucose Transporter 1.
S. L. Pankratz, E. Y. Tan, Y. Fine, A. M. Mercurio, and L. M. Shaw (2009)
J. Biol. Chem. 284, 2031-2037
   Abstract »    Full Text »    PDF »
A Key Tyrosine (Y1494) in the {beta}4 Integrin Regulates Multiple Signaling Pathways Important for Tumor Development and Progression.
U. Dutta and L. M. Shaw (2008)
Cancer Res. 68, 8779-8787
   Abstract »    Full Text »    PDF »
Conditional Deletion of Insulin-like Growth Factor-I Receptor in Prostate Epithelium.
B. W. Sutherland, S. E. Knoblaugh, P. J. Kaplan-Lefko, F. Wang, M. Holzenberger, and N. M. Greenberg (2008)
Cancer Res. 68, 3495-3504
   Abstract »    Full Text »    PDF »
Insulin Receptor Substrate-1 Is an Important Mediator of Ovarian Cancer Cell Growth Suppression by All-trans Retinoic Acid.
S. Ravikumar, G. Perez-Liz, L. Del Vale, D. R. Soprano, and K. J. Soprano (2007)
Cancer Res. 67, 9266-9275
   Abstract »    Full Text »    PDF »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882